Recent Quotes (30 days)

You have no recent quotes
chg | %

ConvaTec Group PLC  

(Public, LON:CTEC)   Watch this stock  
Find more results forCTEC
197.20
-3.80 (-1.89%)
Real-time:   11:41am GMT
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 195.70 - 200.20
52 week 181.98 - 349.10
Open 199.60
Vol / Avg. 1.56M/9.36M
Mkt cap 3,842.69M*
P/E     -
Div/yield 1.06*
EPS -0.11*
Shares 1,951.85M
Beta     -
Inst. own     -
*GBP
Oct 16, 2017
Q3 2017 ConvaTec Group PLC Trading Statement Release and FY2017 Guidance Call (US Analysts and Investors) - Webcast
Oct 16, 2017
Q3 2017 ConvaTec Group PLC Trading Statement Release and FY2017 Guidance Call (UK Analysts & Investors)
Oct 16, 2017
Q3 2017 ConvaTec Group PLC Trading Statement Release and FY2017 Guidance
  

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin 2.91% -12.01%
Operating margin 11.48% 7.82%
EBITD margin - 20.55%
Return on average assets 1.35% -5.55%
Return on average equity 3.70% -39.48%
Employees 8,524 -
CDP Score - -

Address

3 Forbury Place Floor 7, 23 Forbury Road
ICKENHAM, RG1 3JH
United Kingdom - Map

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which provides advanced wound dressings and skin care products; Ostomy Care, which provides devices, accessories and services for people with a stoma, resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity and other causes; Continence and Critical Care, which provides products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida and other causes, and Infusion Devices, which provide disposable infusion sets. Its products include FlexiSeal Signal, FlexiSeal Fecal Collector and Intermittent Catheters.

Officers and directors

Christopher Charles Gent Chairman of the Board
Age: 68
Paul Moraviec Chief Executive Officer, Executive Director
Age: 58
Nigel Clerkin Chief Financial Officer, Executive Director
Age: 43
Frank Schulkes Chief Financial Officer
Symeria Hudson President - Global Franchise & Innovation
Age: 49
Antonio La Regina President - EMEA Region
Age: 55
John Lindskog President - Infusion Devices & Industrial Sales
Age: 58
Timothy Moran President - Americas
Age: 44
George Poole President - APAC Region
Age: 45
Adam Brent Deutsch Executive Vice President, General Counsel
Age: 45